Duffy negative antigen is no longer a barrier to Plasmodium vivax - molecular evidences from the African West Coast (Angola and Equatorial Guinea)

PLoS Neglected Tropical Diseases

Volumn 5, Issue 6, 2011, Pages

  Mendes, Cristina ^a   Dias, Fernanda ^a,b   Figueiredo, Joana ^a   Mora, Vicenta Gonzalez ^c   Cano, Jorge ^c   de Sousa, Bruno ^a   do Rosário, Virgílio E ^a   Benito, Agustin ^c   Berzosa, Pedro ^c   Arez, Ana Paula ^a  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b Universidade Agostinho Neto   (Angola)

^c Red de Investigación de Centros de Enfermedades Tropicales RICET Madrid   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE PROTEIN; DUFFY ANTIGEN; PROTEIN DARC; RIBOSOME RNA; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; DARC PROTEIN, HUMAN; PROTOZOAL PROTEIN; PROTOZOAL RNA;

ANGOLA; ANOPHELES; ARTICLE; BLOOD ANALYSIS; BLOOD GROUP DUFFY SYSTEM; CONTROLLED STUDY; DUFFY ANTIGEN RECEPTOR FOR CHEMOKINE GENE; EQUATORIAL GUINEA; GENE; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PARASITE IDENTIFICATION; PARASITE PREVALENCE; PARASITE TRANSMISSION; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; ADOLESCENT; ADULT; ANIMAL; CHILD; CLASSIFICATION; DISEASE CARRIER; DISEASE TRANSMISSION; FEMALE; GENETICS; GUINEA; INFANT; ISOLATION AND PURIFICATION; MALE; PARASITOLOGY; PATHOGENICITY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANGOLA; ANIMALS; ANOPHELES; CHILD; CHILD, PRESCHOOL; DISEASE VECTORS; DUFFY BLOOD-GROUP SYSTEM; FEMALE; GUINEA; HUMANS; INFANT; MALARIA, VIVAX; MALE; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; RNA, PROTOZOAN; RNA, RIBOSOMAL; YOUNG ADULT;

EID: 79959829832     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001192     Document Type: Article

References (41)

1. Guerra CA, Snow RW, Hay SI, (2006) Mapping the global extent of malaria in 2005. Trends Parasitol 22: 353-358.
2. Galinski MR, Barnwell JW, (2008) Plasmodium vivax: who cares? Malar J 7: S9.
3. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, et al. (2010) The International Limits and Population at Risk of Plasmodium vivax Transmission in 2009. PLoS Negl Trop Dis 4: e774.
4. Baird JK, (2007) Neglect of Plasmodium vivax malaria. Trends Parasit 23: 533-539.
5. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, et al. (2009) Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 9: 555-566.
6. Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, et al. (2008) Plasmodium vivax and Mixed Infections Are Associated with Severe Malaria in Children: A Prospective Cohort Study from Papua New Guinea. PLoS Med 5: 881-889.
7. Rogerson SJ, Carter R, (2008) Severe Vivax Malaria: Newly Recognised or Rediscovered? PLoS Med 5: e136.
8. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, et al. (2008) Multidrug-Resistant Plasmodium vivax Associated with Severe and Fatal Malaria: A Prospective Study in Papua, Indonesia. PLoS Med 5: e128.
9. Alexandre MA, Ferreira CO, Siqueira AM, Magalhães BL, Mourão MPG, et al. (2010) Severe Plasmodium vivax Malaria, Brazilian Amazon. Emerg Infect Dis 16: 1611-1614.
10. Miller LH, Mason SJ, Dvorak JA, McGinniss MH, Rothman IK, (1975) Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 189: 561-563.
11. Langhi DM Jr, Bordin JO, (2006) Duffy blood group and malaria. Hematology 11: 389-398.
12. Culleton RL, Mita T, Ndounga M, Unger H, Cravo PVL, et al. (2008) Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing. Malar J 7: 174.
13. Le Van Kim C, (1995) Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 10: 224-228.
14. Castilho L, Rios M, Pellegrinno J Jr, Saad STO, Costa FF, et al. (2004) A novel FY allele in Brazilians. Vox Sang 87: 190-195.
15. Carvalho TL, Ribolla PEM, Curi RA, Mota LS, (2009) Characterization and transcriptional analysis of the promoter region of the Duffy blood group, chemokine receptor (DARC) in cattle. Vet Immunol Immunopathol 132: 153-159.
16. Cerávolo IP, Bruña-Romero O, Braga EM, Fontes CJ, Brito CF, et al. (2005) Anti-Plasmodium vivax duffy binding protein antibodies measure exposure to malaria in the Brazilian Amazon. Am J Trop Med Hyg 72: 675-681.
17. Beeson JG, Crabb BS, (2007) Towards a Vaccine against Plasmodium vivax Malaria. PLoS Med 4: 1862-1864.
18. Rosenberg R, (2007) Plasmodium vivax in Africa: hidden in plain sight? Trends Parasitol 23: 193-196.
19. Rubio JM, Benito A, Berzosa PJ, Roche J, Puente S, et al. (1999) Usefulness of Seminested Multiplex PCR in Surveillance of Imported Malaria in Spain. J Clin Microbiol 37: 3260-3264.
20. Gautret P, Legros F, Koulmann P, Rodier MH, Jacquemin JL, (2001) Imported Plasmodium vivax malaria in France: geographical origin and report of an atypical case acquired in Central or Western Africa. Acta Trop 78: 177-181.
21. Rubio JM, Benito A, Roche J, Berzosa PJ, García ML, et al. (1999) Semi-nested, multiplex polymerase chain reaction for detection of human malaria parasites and evidence of Plasmodium vivax infection in Equatorial Guinea. Am J Trop Med Hyg 1999 Feb;60 (2): 183-7.
22. Ryan JR, Stoute JA, Amon J, Dunton RF, Mtalib R, et al. (2006) Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya. Am J Trop Med Hyg 75: 575-581.
23. Cavasini CE, de Mattos LC, Couto AA, Couto VS, Gollino Y, et al. (2007b) Duffy blood group gene polymorphisms among malaria vivax patients in four areas of the Brazilian Amazon region. Malar J 6: 167-175.
24. Cavasini CE, Mattos LC, Couto AA, Bonini-Domingos CR, Valencia SH, et al. (2007a) Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception? Trans R Soc Trop Med Hyg 101: 1042-1044.
25. Ménard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, et al. (2010) Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci U S A 107: 5967-5971.
26. Qari SH, Shi YP, Goldman IF, Udhayakumar V, Alpers MP, et al. (1993) Identification of Plasmodium vivax-like human malaria parasite. Lancet 341: 780-783.
27. Kappe SH, Buscaglia CA, Nussenzweig V, (2004) Plasmodium sporozoite molecular cell biology. Annu Rev Cell Dev Biol 20: 29-59.
28. Rosenberg R, Wirtz RA, Lanar DE, Sattabongkot J, Hall T, et al. (1989) Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. Science 245: 973-976.
29. Souza-Neiras WC, Storti-Melo LM, Cassiano GC, Couto VS, Couto AA, et al. (2010) Plasmodium vivax circumsporozoite genotypes: a limited variation or new subspecies with major biological consequences? Malar J 9: 178.
30. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE, (1995) Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 52: 565-568.
31. Arez AP, Lopes D, Pinto J, Franco AS, Snounou G, et al. (2000) - Plasmodium sp.: Optimal protocols for PCR amplification from mosquito (Anopheles sp.) samples. Exp Parasitol 94: 269-272.
32. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN, (1993) Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of high prevalence of mixed infections. Mol Biochem Parasitol 58: 283-292.
33. Alves RT, Póvoa MM, Goldman IF, Cvasini CE, Rossit ARB, et al. (2007) A new polymerase chain/restriction fragment length polymorphism protocol for Plasmodium vivax circumsporozoite protein genotype (VK210, VK247 and P. vivax-like) determination. 59: 415-419.
34. Barcus MJ, Basri H, Picarima H, Manyakori C, Sekartuti, et al. (2007) Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg 77: 984-991.
35. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, et al. (2007) Vivax malaria: neglected and not benign. Am J Trop Med Hyg 77: 79-87.
36. Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, et al. (2009) Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg 80: 194-198.
37. Gautret P, Legros F, Koulmann P, Rodier MH, Jacquemin JL, (2001) Imported Plasmodium vivax malaria in France: geographical origin and report of an atypical case acquired in Central or Western Africa. Acta Trop 78: 177-181.
38. Snounou G, Pinheiro L, Antunes AM, Ferreira C, do Rosario VE, (1998) Nonimmune patients in the Democratic Republic of Sao Tome e Principe reveal a high level of transmission of P. ovale and P. vivax despite low frequency in immune patients. Acta Trop 70: 197-203.
39. Poirriez J, Landau I, Verhaeghe A, Savage A, Dei-Cas E, (1991) [Atypical forms of Plasmodium vivax. Apropos of a case]. Ann Parasitol Hum Comp 66: 149-154.
40. Collins WE, Roberts JM, (1991) Anopheles gambiae as a host for geographic isolates of Plasmodium vivax. 7: 569-573.
41. Michon P, Stevens JR, Kaneko O, Adams JH, (2002) Evolutionary relationships of conserved cysteine-rich motifs in adhesive molecules of malaria parasites. Mol Biol Evol 19: 1128-42.